The results indicated that with the treatment of growth factors such as TGF-β1, activin A, BMP-4, and hepatocyte growth factor (HGF), human ES-derived cells can be differentiated into cells expressing Wilms tumor (WT)-1 and the glomerular marker gene rennin in vitro49 (Fig. 2). This evidence concerns the gene HGF and Wilms tumor.